Across 15 randomised trials with 714 participants, resveratrol supplementation produced no significant change in liver enzymes: ALT, AST, GGT, alkaline phosphatase and bilirubin all held statistically steady.
What it shows: Meta-analysis of 15 RCTs (714 adults); heterogeneity was high for some enzymes (I² up to 82.9%), and subgroup analyses hint that dose, duration and population status could matter, but the pooled result was null across the board.Meta-analysis · Int J Clin Pract